Skip to main content
MINGCHEN HEALTH Co.,Ltd. logo

MINGCHEN HEALTH Co.,Ltd. — Investor Relations & Filings

Ticker · 002919 ISIN · CNE1000033B9 Shenzhen Stock Exchange Manufacturing
Filings indexed 903 across all filing types
Latest filing 2023-04-26 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002919

About MINGCHEN HEALTH Co.,Ltd.

https://www.mingchen.com.cn

MINGCHEN HEALTH Co.,Ltd. operates a dual-core business strategy encompassing personal care products and mobile game development. The personal care segment focuses on the research, development, manufacturing, and distribution of hair care, skin care, and body cleansing products. It manages a portfolio of established brands catering to diverse consumer needs through extensive retail and distribution networks. The digital entertainment segment specializes in the creation, publishing, and operation of mobile games, utilizing internal development teams and strategic partnerships to reach global audiences. By integrating traditional consumer goods manufacturing with high-growth digital sectors, the company maintains a diversified portfolio centered on consumer health and lifestyle entertainment.

Recent filings

Filing Released Lang Actions
年度募集资金使用鉴证报告
Audit Report / Information Classification · 95% confidence The document is a detailed report on the 2022 annual status of funds raised by the company, including the storage and actual use of the raised funds. It includes an auditor's assurance report (鉴证报告) from a certified accounting firm, referencing compliance with regulatory guidelines on the management and use of raised funds. The document contains detailed financial data on the amounts raised, used, and remaining, as well as explanations of project terminations and fund reallocations. It is not a general annual report (10-K), but a specialized audit-related report focusing on the use of raised capital. It is not a mere announcement or certification but contains substantive financial and operational data. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to specific financial matters, excluding full annual reports. Therefore, the document should be classified as AR with high confidence. FY 2022
2023-04-26 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding various reports and proposals related to the company's 2022 annual report, financial statements, profit distribution, internal control self-assessment, audit firm appointment, and the 2023 first quarter report. It references multiple reports that have been or will be disclosed elsewhere (e.g., on cninfo.com.cn and newspapers). The document itself does not contain the full annual report or financial statements but summarizes the Supervisory Board's review and approval of these items and states that these reports will be submitted to the shareholders' meeting for approval. The document length is 3494 characters, which is relatively short and mainly serves as an announcement of the Supervisory Board meeting resolutions rather than the full reports themselves. Therefore, according to the "Menu vs Meal" rule, this document is best classified as a Regulatory Filing (RNS) because it is a formal announcement of supervisory board resolutions and references other filings but does not contain the full reports or detailed financial data itself.
2023-04-26 Chinese
2022年度独立董事述职报告(高慧)
Management Reports Classification · 95% confidence The document is titled '2022 年度独立董事述职报告' which translates to '2022 Annual Independent Director's Work Report'. It details the independent director's attendance at board and shareholder meetings, independent opinions on various company matters, committee participation, on-site investigations, and efforts to protect investor rights during the 2022 fiscal year. The content is a detailed management report on the independent director's activities and oversight during the year, rather than a full annual report or audit report. It does not contain financial statements or earnings data but focuses on management and governance activities. Therefore, it fits best under the category of Management Reports (MDA). The document length is 3173 characters, which is consistent with a detailed report but not a full annual report. No indication that this is a report publication announcement or a regulatory filing. Hence, the classification is MDA with high confidence.
2023-04-26 Chinese
2022年年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2022 annual performance forecast (业绩预告) for the company 名臣健康用品股份有限公司. It provides estimated financial results for the full year 2022, including net profit and earnings per share, and explains reasons for performance changes. It explicitly states that the forecast is based on internal financial department calculations and has not been audited by an accounting firm. It also includes a risk warning that the final audited financial data will be disclosed in the 2022 annual report. The document is relatively short (1303 characters) and serves as a preliminary earnings forecast rather than a full financial report. This type of document is best classified as an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only, rather than a full Annual Report (10-K) or Interim Report (IR). FY 2022
2023-04-18 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations of the company 名臣健康用品股份有限公司. It explains the situation, confirms no undisclosed material information, and provides risk warnings related to a share repurchase plan. The document does not contain financial statements, detailed financial performance data, or management discussion of results. It is a regulatory announcement about stock trading behavior and company disclosures, not a financial report or earnings release. The document length is short (1926 characters) and it serves as a formal disclosure to comply with stock exchange rules. Therefore, it fits best under Regulatory Filings (RNS).
2023-04-05 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase program. It details the number of shares repurchased, prices, compliance with regulatory guidelines, and future intentions. It does not contain full financial statements or comprehensive financial analysis but focuses on the status and details of the share buyback activity. The document length is about 2076 characters, which is relatively short and focused on a specific capital activity. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers announcements of share repurchases or sales by the company itself.
2023-04-03 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.